The life sciences are said to be in the midst of a replication crisis because (1) a majority of published results are irreproducible, and (2) scientists rarely replicate existing data. Here I argue that point 2 of this assessment is flawed because there is a hitherto unidentified form of replication in the experimental life sciences, which I call ‘microreplications’ (MRs). Using a case study from biochemistry, I illustrate how MRs depend on a key element of experimentation, namely, experimental controls. I end by reflecting on what MRs mean for the broader debate about the replication crisis.
No takes yet. Share an insight, caveat, or question.
Stephan Güttinger (2019) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: